Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!
Fill out the form to gain access to exclusive content and data-driven strategies
In the complex and dynamic field of oncology, organisations must swiftly interpret performance data across multiple product lines, regions and channels. This case study from DelveInsight focuses on an oncology product assessment dashboard designed to allow a global pharmaceutical company to monitor new-asset performance based on both lead and lag KPIs.
The goal: turn raw information into actionable insights by centralising metrics, reducing lag in interpretation, and enabling strategic decision-making.
The client faced the challenge of handling a wide variety of newly-launched oncology products across multiple locally operating countries (LOCs). Their key problems:
DelveInsight implemented a structured methodology to overcome these issues:
The result: a web-based interactive KPI dashboard built by DelveInsight that offers visualisations, monthly executive summaries, and evolution indices to compare individual country performance.
Thanks to DelveInsight’s dashboard solution, the client gained:
DelveInsight’s oncology product assessment dashboard converted a complex, multi-country data challenge into a powerful strategic tool delivering visibility, comparability and insight across lead and lag KPIs in one unified interface.

